Wall Street analyst estimates for Autonomix Medical, Inc. (AMIX): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals.
Analyst Consensus
| Strong Buy | 0 |
| Buy | 1 |
| Hold | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total analysts | 1 |
| Avg rating (1-5) | 1.00 |
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-11-11 | $-6.20 | ||
| 2026-08-12 | $-5.02 | $-6.40 | +21.6% |
| 2026-06-04 | $-4.83 | $-4.83 | +0.0% |
| 2026-02-12 | $-7.56 | $-7.56 | +0.0% |
| 2025-11-14 | $-28.98 | $-31.50 | +8.0% |
| 2025-08-13 | $-22.47 | $-18.59 | -20.9% |
| 2025-05-29 | $-38.53 | $-25.93 | -48.6% |
| 2025-02-11 | $-30.66 | $-30.66 | +0.0% |
Valuation Ratios
| Price / Book | 0.70 |
| EV / EBITDA | 0.06 |
| Dividend Yield | 0.00% |
Income Statement (10y)
| Year | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | $12000 |
| Gross Profit | 0 | 0 | 0 | 0 | -$12000 |
| Research & Development | $4069 | $745000 | $2.2M | $4.7M | $7.1M |
| Selling, General & Admin | $13.6M | $1.2M | $5.2M | $6.9M | $9.9M |
| Operating Expenses | $13.6M | $2.0M | $12.0M | $11.6M | $17.0M |
| Operating Income | -$13.6M | -$2.0M | -$12.0M | -$11.6M | -$17.0M |
| EBITDA | -$13.6M | -$2.0M | -$15.3M | -$11.1M | -$17.0M |
| Interest Expense | $218088 | 0 | $79000 | $176000 | 0 |
| Pre-tax Income | -$13.3M | -$2.0M | -$15.4M | -$11.4M | -$16.7M |
| Income Tax | 0 | 0 | 0 | 0 | 0 |
| Net Income | -$13.3M | -$2.0M | -$15.4M | -$11.4M | -$16.7M |
| EPS | $-286.98 | $-44.48 | $-343.78 | $-135.65 | $-48.64 |
| EPS (Diluted) | $-286.98 | $-44.48 | $-343.78 | $-135.65 | $-48.64 |
| Shares Outstanding (Diluted) | $44747 | $44747 | $44871 | $84115 | $343655 |
Price
| Price | $4.12 |
| Market Cap | $2M |
| Exchange | NASDAQ |
| Country | US |
Related companies: AIM · BBLG · DHAI · FLGC · HSCS · KALA · MOVE
Explore sector: Healthcare · Medical - Devices
More sections of AMIX: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks